Ceramide in Rafts (detergent-insoluble fraction) mediates cell death in neurotumor cell lines

Journal of Neuroscience Research

Volumn 72, Issue 1, 2003, Pages 65-75

  Kilkus, John ^a   Goswami, Rajendra ^a   Testai, Fernando D ^a   Dawson, Glyn ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Apoptosis; Ceramide; Neutral sphingomyelinase; Programmed cell death; Rafts

Indexed keywords

ALPHA LEVO FUCOSIDASE; CASPASE 8; CERAMIDE; CHOLESTEROL; CYCLODEXTRIN DERIVATIVE; DETERGENT; FUMONISIN B1; HYDROLASE; PALMITIC ACID; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; STAUROSPORINE; SUCROSE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID MEMBRANE; LIPOGENESIS; NERVE CELL NECROSIS; NERVE TUMOR; NEUROBLASTOMA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; SPINAL GANGLION; ULTRACENTRIFUGATION;

CELL DEATH; CELL LINE; CERAMIDES; HUMANS; MEMBRANE MICRODOMAINS; NEUROBLASTOMA; OLIGODENDROGLIOMA; TUMOR CELLS, CULTURED;

EID: 0037381124     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10549     Document Type: Article

References (50)

1. Anderson RGW. 1998. The caveolae membrane system. Annu Rev Biochem 67:199-225.
2. Ariga T, Jarvis WD, Yu RK. 1998. Role of sphingolipid-mediated cell death in neurodegenerative diseases. J Lipid Res 39:1-16.
3. Chalfant CE, Kishikawa K, Mumby MC, Kamibayashi C, Bielawska A, Hannun Y. 1999. Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. J Biol Chem 274:20313-20317.
4. Cho S, Dawson G. 2000. Palmitoyl protein thioesterase 1 protects against apoptosis mediated by Ras-Akt-caspase pathway in neuroblastoma cells. J Neurochem 74:1478-1488.
5. Dawkins JL, Hulme DJ, Brahmbhatt SB, Auer-Grumbach M, Nicholson GA. 2001. Mutations in SPTLC1, encoding serine palmitoyltransferase, long-chain base subunit-1, cause hereditary sensory neuropathy type 1. Nat Genet 27:309-312.
6. Goswami R, Dawson G. 2000. Does ceramide play a role in neural cell apoptosis? J Neurosci Res 60:141-149.
7. Goswami R, Kilkus J, Dawson S, Dawson G. 1999. Overexpression of Akt (protein kinase B) confers protection against apoptosis and prevent formation of ceramide in response to pro-apoptotic stimuli. J Neurosci Res 57:884-893.
8. Grassme H, Jekle A, Riehle A, Schwarz H, Berger J, Sandhoff K, Kolesnick R, Gulbins E. 2001. CD95 signaling via ceramide-rich membrane Rafts. J Biol Chem 276:20589-20596.
9. Grazide S, Maestre N, Veldman RJ, Bezombes C, Maddens S, Levade T, Laurent G, Jaffrezou JP. 2002. Ara-C and daunorubicin-induced recruitment of Lyn in sphingomyelinase-enriched membrane rafts. FASEB J 16:1685-1687.
10. Grullich C, Sullards MC, Fuks Z, Merrill AH, Kolesnick R. 2000. CD95 signals ceramide generation independent of the effector stage of apoptosis J Biol Chem 275:8650-8656.
11. Hannun YA. 1994. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269:3125-3128.
12. Hofmann K, Tomiuk S, Wolff G, Stoffel W. 2002. Cloning and characterization of the mammalian brain-specific, Mg-dependent neutral sphingomyelinase. Proc Natl Acad Sci USA 97:5895-5900.
13. Irie F, Hirabayashi Y. 1998. Application of exogenous ceramide to cultured rat spinal motorneurons promote survival or death by regulation of apoptosis depending on its concentrations. J Neurosci Res 54:475-485.
14. Kim T, Pfeiffer SE. 1999. Myelin glycosphingolipid/cholesterol-enriched microdomains selectively sequester the non-compact myelin proteins CNP and MOG. J Neurocytol 28:281-293.
15. Kim T, Pfeiffer SE. 2002. Subcellular localization and detergent solubility of MVP17/rMAL, a lipid Raft-associated protein in oligodendrocytes and myelin. J Neurosci Res 69:217-226.
16. Kirschnek S, Paris F, Weller M, Grassme H, Ferlink K, Riehle A, Fuks K, Kolesnick R, Gulbins E. 2000. CD-95-mediated apoptosis in vivo involves acid sphingomyelinase. J Biol Chem 275:27316-27323.
17. Kolesnick R, Golde D. 1994. The sphingomyelin pathway in tumor necrosis factor and interlukin-1 signaling. Cell 77:325-328.
18. Kramer EM, Klein C, Koch T, Boytinck M, Trotter J. 1999. Compartmentation of Fyn kinase with glycosylphosphatidylinositol-anchored molecules in oligodendrocytes facilitates kinase activation during myelination. J Biol Chem 274:29042-29049.
19. Lee AG. 2001. Myelin: delivery by Raft. Curr Biol 11:R60-R62.
20. Lin T, Genestier L, Fuks K, Schuchman EH, Kolesnick RN, Green DR. 2000. Role of acid sphingomyelinase in Fas/CD95-mediated cell death. J Biol Chem 275:8657-8663.
21. Liu P, Anderson RG. 1995. Compartmentalized production of ceramide at the cell surface. J Biol Chem 270:27179-27185.
22. Luberto C, Hassler DF, Signorelli P, Okamoto Y, Sawai H, Boros, E, Hazen-Martin DJ, Obeid L, Hannun Y, Smith GK. 2002. Inhibition of TNF-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J Biol Chem 277:41128-41139.
23. Mayo LD, Donner DB. 2001. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci USA 98:11598-11603.
24. Merrill AH Jr, Schmelz EM, Dillehay DL, Spiegel S, Shayman JA, Schroeder JJ, Riley RT, Voss KA, Wang E. 1997. Sphingolipids - the enigmatic lipid class: biochemistry, physiology and pathophysiology. Toxicol Appl Pharmacol 142:208-225.
25. Neuberger Y, Shogomori H, Levy Z, Fainzilber M, Futerman AH. 2000. A lyso-platelet activating factor phospholipase C, originally suggested to be a neutral-sphingomyelinase, is located in the endoplasmic reticulum. FEBS Lett 469:44-46.
26. Nix M, Stoffel W. 2001. Perturbation of membrane microdomains reduces mitogenic signaling and increases susceptibility to apoptosis after T cell receptor stimulation. Cell Death Differ 7:413-424.
27. Perry DK, Carton J, Shah AK, Meredith F, Uhlinger DJ, Hannun Y. 2000. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J Biol Chem 275:9078-9084.
28. Post GR, Dawson G. 1992. Characterization of a cell line derived from a human oligodendroglioma. Mol Chem Neuropathol 16:308-317.
29. Prinetti A, Chigorno V, Prioni S, Loberto N, Tettamanti G, Sonnino S. 2001. Changes in the lipid turnover, composition, and organization as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro. J Biol Chem 276:21136-21145.
30. Roy S, Nicholson DW. 2000. programmed cell death regulation: basic mechanisms and therapeutic opportunities. Mol Med Today 6:264-266.
31. Schade AE, Levine AD. 2001. Lipid Raft heterogeneity in human peripheral blood T lymphoblasts: a mechanism for regulating the initiation of TCR signal transduction. J Immunol 168:2233-2239.
32. Scurlock BK, Dawson G. 1999. Differential responses of oligodendrocytes to tumor necrosis factor and other pro-apoptotic agents: role of ceramide in apoptosis. J Neurosci Res 55:514-522.
33. Segui B, Kronke M, Levade T. 1999. CD40 signals apoptosis through FAN-regulated activation of the sphingomyelin-ceramide pathway. J Biol Chem 274:37251-37258.
34. Sheets ED, Holowka D, Baird B. 1999. Critical role for cholesterol in lyn-mediated tyrosine phosphorylation of FceRI and their association with detergent-resistant membranes. J Cell Biol 145:877-887.
35. Sillence DJ. 2001. Apoptosis and signalling in acid sphingomyelinase deficient cells. BMC Cell Biol 2:24-27.
36. Simons K, Gruenberg J. 2000. Jamming the endosomal system: lipid Rafts and lysosomal storage diseases. Cell Biol 10:459-463.
37. Smart EJ, Graf G, Lisanti MP. 1999. Caveolins, liquid-ordered domains and signal transduction. Mol Cell Biol 19:7289-730.
38. Tepper A, deVries E, Blitterswijk WJV, Borst J. 1999. Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD-95 and DNA damage-induced apoptosis. J Clin Invest 103:971-977.
39. Tomiuk S, Hofmann K, Nix M, Zumbansen M, Stoffel W. 1998. Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc Natl Acad Sci USA 95:3638-3643.
40. Tsui-Pierchala BA, Encinas M, Milbrandt J, Johnson EM Jr. 2002. Lipid Rafts in neuronal signaling and function. Trends Neurosci 8:12-17.
41. Veldman RJ, Maestre N, Aduib OM, Medin JA, Salvayre R, Levade T. 2001. A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumor necrosis factor signaling. Biochem J 355:859-868.
42. Vielhaber G, Brade L, Wepf R, Wittern K-P, Brade H. 2001. Mouse anti-ceramide antiserum: a specific tool for the detection of endogenous ceramide. Glycobiology 11:451-457.
43. Wiesner DA, Dawson G. 1996. Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway. J Neurochem 66:1418-1425.
44. Wiesner DA, Kilkus JP, Gottschalk AR, Quintans J, Dawson G. 1997. Anti-immunoglobulin-induced apoptosis in WEHI-231 cells involves the slow formation of ceramide from sphingomyelin and is blocked by bcl-xL. J Biol Chem 272:9868-9876.
45. Xu J, Chen-Hsiung Y, Hsu CY. 1998. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-α/cycloheximide-induced cerebral endothelial cell death. J Biol Chem 273:16521-16526.
46. Yu ZF, Nikolova-Karaskashian M, Zhou D, Cheng G, Schuchman EH, Mattson MP. 2000. Pivotal role for acid sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production and neuronal apoptosis. J Mol Neurosci 15:85-97.
47. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC. 2001. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3:245-252.
48. Zhou H, Summers SA, Birnbaum MJ, Pittman R. 1998. Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J Biol Chem 273:16568-16575.
49. Zumbansen M, Stoffel W. 2002. Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease. Mol Cell Biol 11:3633-3638.
50. Zundel W, Swiersz LM, Giaccia A. 2000. Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide. Mol Cell Biol 20:1507-1514.